HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysisM. Juliana McElrath, Danilo R. Casimiro, Stephen C. De Rosa et al.|The Lancet|2008Cited by 699
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b studyGlenda Gray, James G. Kublin, Barbara Metch et al.|The Lancet Infectious Diseases|2011Cited by 385
Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy AdultsFrances Priddy, Deborah D. Brown, James G. Kublin et al.|Clinical Infectious Diseases|2008Cited by 246
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trialMorgane Rolland, James I. Mullins, Sodsai Tovanabutra et al.|Nature Medicine|2011Cited by 227